300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Enterprise
Community
Media (Entertainment)
Impact
Sustainability
Hardware
Biotech
Transportation
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Egypt
Gibraltar
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Kuwait
Czech Republic
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Paraguay
Seychelles
Botswana
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Bulgaria
Azerbaijan
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Ecuador
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Startup Investors in Italy (October 2026)

The most active venture capital funds and angel investors investing in Italy Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Italy Medical startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
CDP Venture Capital
VC Fund
16 Italy, United States, Switzerland Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $483k–$23M
Italian Angels for Growth
VC Fund
8 Italy, United States, United Kingdom Seed, Angel, Series A Software, E-Commerce, Health Care $219k–$14M
Panakes Partners
VC Fund
6 Italy, Switzerland, United Kingdom Series B, Series A, Series C Health Care, Medical, Biotechnology $4.5M–$110M
Innogest Capital
VC Fund
6 Italy, United States, Spain Series A, Venture - Series Unknown, Series B Health Care, Medical, Medical Device $1.1M–$32M
LIFTT
VC Fund
5 Italy, United Kingdom, France Seed, Series A, Venture - Series Unknown Biotechnology, Software, Health Care $338k–$118M
CDP Equity
VC Fund
4 Italy, United States, United Kingdom Seed, Series A, Pre-Seed Information Technology, Software, Health Care $177k–$13M
Indaco Venture Partners
VC Fund
4 Italy, United Kingdom, Switzerland Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2.3M–$89M
Vertis
VC Fund
4 Italy, United States, United Kingdom Seed, Series A, Venture - Series Unknown Software, Health Care, Biotechnology $823k–$25M
Invitalia Ventures
VC Fund
4 Italy, United States, United Kingdom Series A, Seed Software, Medical, B2B $292–$6.2M
Scientifica Venture Capital
VC Fund
3 Italy, Sweden, Finland Seed, Pre-Seed Biotechnology, Health Care, Manufacturing $209k–$2.9M
XGEN Venture
VC Fund
3 Italy, Sweden, Germany Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $4.6M–$141M
INGENIUM Emilia Romagna
VC Fund
3 Italy Seed, Series A, Angel Medical, Biotechnology, Health Care $663k–$2.8M
Lazio Innova
VC Fund
3 Italy, United Kingdom Seed, Pre-Seed, Grant Health Care, Software, Biotechnology $22k–$1.9M
Angelini Ventures
VC Fund
3 United States, Italy, France Series A, Seed, Series B Health Care, Biotechnology, Medical $3.3M–$132M
La Finanziaria Trentina
VC Fund
2 Italy Venture - Series Unknown, Private Equity Health Care, Retail, Medical $910k–$4.6M
Principia SGR
VC Fund
2 Italy, United States, United Kingdom Series A, Venture - Series Unknown Health Care, Biotechnology, Software $1.5M–$9.9M
Luca Trevisan
Angel
2 Italy Series A Medical, Health Care, Medical Device $750k–$1.4M
Fountain Healthcare Partners
VC Fund
2 Ireland, United States, France Series A, Series B, Series C Health Care, Biotechnology, Medical $3.3M–$110M
Equiter
VC Fund
2 Italy Seed, Series B Medical, Health Care, Information Technology $2.2M–$4M
European Investment Bank
VC Fund
2 France, Germany, Spain Debt Financing, Post-IPO Debt, Venture - Series Unknown Biotechnology, Energy, Health Care $8.7M–$587M
Club degli Investitori
VC Fund
2 Italy, Switzerland, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, E-Commerce $197k–$30M
P101
VC Fund
2 Italy, Spain, United States Seed, Series A, Venture - Series Unknown Software, E-Commerce, Information Technology $270k–$15M
ENEA Tech e Biomedical
VC Fund
2 Italy, Finland Venture - Series Unknown, Series A, Grant Health Care, Biotechnology, Medical Device $530k–$21M
Fin Posillipo Spa
VC Fund
2 Italy, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Sales, Medical, Internet $140k–$162k
Sefea Impact
VC Fund
2 Italy Venture - Series Unknown, Seed, Series A Medical, Health Care, Information Services $777k–$5.9M
Neva SGR
VC Fund
2 Italy, United States, Israel Series B, Series A, Series C Software, FinTech, Information Technology $6M–$141M
Fondazione Social Venture Giordano dell'Amore
VC Fund
2 Italy, Mexico Venture - Series Unknown, Seed, Pre-Seed Health Care, Software, Information Technology $29k–$841k
Lumen Ventures
VC Fund
2 Italy, United States Seed, Series A, Pre-Seed Health Care, Medical, Software $1.4M–$14M
3B Future Health Fund
VC Fund
2 United States, Italy, United Kingdom Series B, Series A, Seed Biotechnology, Therapeutics, Medical $1.5M–$75M
Opes Italia
VC Fund
2 Italy, Spain Venture - Series Unknown, Series A, Seed E-Commerce, Leisure, Medical $440k–$7.5M
Antin Infrastructure Partners
VC Fund
2 United States, Italy, United Kingdom Private Equity, Seed Energy, Renewable Energy, Commercial $108M–$1B
Alchimia Investments
VC Fund
2 Italy, United Kingdom, Israel Series A, Seed, Venture - Series Unknown Software, Health Care, Medical $2.3M–$40M
The Techshop
VC Fund
2 Italy, Portugal, Switzerland Seed, Pre-Seed, Series A Artificial Intelligence, Software, FinTech $322k–$120M
Evotec
VC Fund
2 United States, Germany, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $8.5M–$139M
Green Arrow Capital
VC Fund
1 Italy, United Kingdom Seed, Series A Health Care, Biotechnology, Manufacturing $1.5M–$2.2M
Fondazione Golinelli
VC Fund
1 Italy Seed, Pre-Seed, Grant FinTech, Medical, Biotechnology $146k–$534k
Padda Health
VC Fund
1 Italy, Germany, Luxembourg Seed, Pre-Seed, Venture - Series Unknown Health Care, Artificial Intelligence, Medical $244k–$2.6M
Giovanni Cerutti
Angel
1 Italy Medical, Wellness, Health Care
Kairos Partners
VC Fund
1 Italy Seed, Series A FinTech, Financial Services, Fashion $2M–$11M
Spindial Group
VC Fund
1 Italy Medical, Health Care, Biotechnology
Romed
VC Fund
1 Italy Medical, Wellness, Health Care
VI Partners
VC Fund
1 Switzerland, Germany, United States Series A, Series B, Seed Health Care, Biotechnology, Software $1.3M–$41M
Seroba Life Sciences
VC Fund
1 Ireland, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $4.6M–$105M
RoboIT
VC Fund
1 Italy Pre-Seed Medical, Manufacturing, Medical Device
Growth Engine
VC Fund
1 Italy, Mexico, United Kingdom Seed, Secondary Market, Convertible Note Software, E-Commerce, Information Technology
RECOMEC
VC Fund
1 Italy Medical, Health Care, Biotechnology
Fondazione Cottino
VC Fund
1 Italy Seed Medical, mHealth, Diabetes
Ferrante Gaetani,
Angel
1 Italy Series A Medical, Health Care, Medical Device
Metaventures
VC Fund
1 Italy, Brazil, United Kingdom Venture - Series Unknown Gaming, Medical, PC Games $174k–$8M
Claris Ventures
VC Fund
1 Italy, United Kingdom Seed, Series A, Series B Biotechnology, Health Care, Therapeutics $2.2M–$25M
Access all 203 investors in Italy Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 16 investments in Italy Medical startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United States, Switzerland

Investor stats

  • Total investments: 301
  • Round size: Seed $483k–$8.1M; Series A $3.3M–$23M; Venture - Series Unknown $652k–$16M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $212M in 2021

Portfolio highlights

  • Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
  • Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
Show all investments...

Italian Angels for Growth
VC Fund · Milan, Lombardia, Italy · 8 investments in Italy Medical startups

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Angel, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 106
  • Round size: Seed $331k–$5.1M; Angel $219k–$987k; Series A $3M–$14M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
  • AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
  • Alomana — Autonomous systems for enterprise
Show all investments...

Panakes Partners
VC Fund · Milano, Lombardia, Italy · 6 investments in Italy Medical startups

Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 42
  • Round size: Series A $4.5M–$79M; Series B $10M–$60M; Series C $18M–$110M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — raised $187M in 2023

Portfolio highlights

  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
  • Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Show all investments...

Innogest Capital
VC Fund · Milan, Lombardia, Italy · 6 investments in Italy Medical startups

We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Italy, United States, Spain

Investor stats

  • Total investments: 68
  • Round size: Series A $1.1M–$11M; Series B $2.7M–$32M; Venture - Series Unknown $1.6M–$12M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $95M in 2015

Portfolio highlights

  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
  • BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.
Show all investments...

LIFTT
VC Fund · Turin, Piemonte, Italy · 5 investments in Italy Medical startups

A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 75
  • Round size: Seed $338k–$4.7M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
  • Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
  • Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Show all investments...

CDP Equity
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Medical startups

CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Seed $177k–$3.6M; Pre-Seed $230k–$3.6M; Series A $2.3M–$13M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Gility — Gility is a digital learning platform that collaborates with business schools and training institutions for an effective training offer. Established in 2022, it was supported by CDP Venture Capital and BPER Banca.
  • Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
  • Valvitalia SpA. — VALVITALIA is a leading group in the field of design, production, and overall supply of equipment and components intended for the petroleum, water, natural gas industries, and petrochemical industry as well as electrical power stations. The group works mainly with valves (core product), actuators, pipe fittings, flanges and systems for measuring,filtering, and regulating fluids and gases and with FireFighting systems. VALVITALIA was set up with the precise objective of becoming the leading Italian group able to offer such a wide range of products and to compete with the large American multinationals that have always dominated this field. This young company has extensive experience in the sector, thanks to its professional management and historical brands in the valve world that have been taken on by the Group, including: ROTOR, DELTA V.E., THEVIGNOT, VANADOUR, VITAS, TORMENE T.G.T. and TECNOFORGE. VALVITALIA has always included safety and respect for the environment and its employees among its priorities.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Medical startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Italy, United Kingdom, Switzerland

Investor stats

  • Total investments: 49
  • Round size: Series A $3.5M–$33M; Series B $8.9M–$89M; Venture - Series Unknown $2.3M–$21M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $302M in 2018

Portfolio highlights

  • Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
  • Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

Vertis
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Medical startups, 10 in the past 12 months

Capitali e competenze per accelerare l'innovazione. Attraverso fondi di investimento chiusi investiamo in startup, scaleup e PMI innovative

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $823k–$4M; Series A $1.5M–$11M; Venture - Series Unknown $1.1M–$25M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $49M in 2021

Portfolio highlights

  • Clastix — Kubernetes multi-tenancy made easy
  • Tiledesk — Boost customer engagement with Tiledesk. Discover our conversational automation ready to use. Personalized experiences, improved conversion and retention.
  • Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.
Show all investments...

Invitalia Ventures
VC Fund · Rome, Lazio, Italy · 4 investments in Italy Medical startups

Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it

Show more...

Investment focus

  • Industry: Software, Medical, B2B
  • Stage:Series A, Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 30
  • Round size: Seed $292–$1.6M; Series A $900k–$6.2M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $103M in 2017

Portfolio highlights

  • Ecomate — The ESG Rating platform for every company
  • BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
  • Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Show all investments...

Scientifica Venture Capital
VC Fund · Roma, Lazio, Italy · 3 investments in Italy Medical startups

Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: Italy, Sweden, Finland

Investor stats

  • Total investments: 17
  • Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
  • Lead/follow: 76% lead, 24% follow
  • Last fund: Likely actively investing — fresh fund, raised $209M in 2024

Portfolio highlights

  • Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
  • OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
  • LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
XGEN Venture
VC Fund · Milan, Lombardia, Italy · 3 investments in Italy Medical startups, 6 in the past 12 months

XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) with over 15 years of experience in the startup process and the development of innovative solutions for high unmet medical needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Italy, Sweden, Germany

Investor stats

  • Total investments: 11
  • Round size: Series A $11M–$98M; Series B $4.6M–$141M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: Likely actively investing — fresh fund, raised $186M in 2024

Portfolio highlights

  • Dialybrid — Dialybrid provide product that include silkothane arteriovenous graft, SAG biomimetic nanostructure, and situ tissue engineering products. Their proprietary innovative technology, silkothane, is a hybrid material combining silk fibroin and polyurethane. Their aim is to develop a novel semi-degradable vascular access for hemodialysis.
  • EpilepsyGTx — EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy (FRE).
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

INGENIUM Emilia Romagna
VC Fund · 3 investments in Italy Medical startups

INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: Italy

Investor stats

  • Total investments: 8
  • Round size: Seed $663k–$2.8M; Series A $1.1M–$2.2M
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • Fazland — Smart solutions to daily problems.
  • Passpack — Users can make and store passwords in a single, organized list, then access them from anywhere leaving no traces behind on the computer. Secure collaboration features allow users to make, send, share or provision passwords to colleagues, clients and partners -- a secure alternative to spreadsheets in the workplace. Managed via a central onlinerepository.Passpack is a free, professional tool. Optional premium upgrades are available for the micro-small business sector.
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
Show all investments...

Lazio Innova
VC Fund · Rome, Lazio, Italy · 3 investments in Italy Medical startups

Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Pre-Seed, Grant
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 35
  • Round size: Seed $400k–$1.9M; Grant $22k–$343k; Pre-Seed $58k–$518k
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • HEU — Draft, sign and store contracts in one place. AI extracts deadlines and clauses, signatures valid in 180+ countries.
  • Tech4All — We support the study by using AI.
  • GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Show all investments...

Angelini Ventures
VC Fund · Rome, Lazio, Italy · 3 investments in Italy Medical startups, 12 in the past 12 months

Angelini Ventures is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: United States, Italy, France

Investor stats

  • Total investments: 35
  • Round size: Seed $3.3M–$45M; Series A $11M–$105M; Series B $19M–$132M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Epicrispr Biotechnologies — The Gene Expression Modulation System (GEMS) technology from Epic-Bio combines a DNA-binding protein, a tailored guide RNA, and any of a wide range of modulator proteins to generate a powerful new type of genetic medicine. GEMS medicines have the ability to precisely modify gene expression both in and out of the body. They are mutation-independent,which means that a single GEMS design can address the majority or all genetic subtypes of a disease.
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

La Finanziaria Trentina
VC Fund · Trento, Trentino-Alto Adige, Italy · 2 investments in Italy Medical startups

La Finanziaria Trentina is s a private equity firm. It invests in energy, infrastructure, and real estate sectors.

Show more...

Investment focus

  • Industry: Health Care, Retail, Medical
  • Stage:Venture - Series Unknown, Private Equity
  • Geography: Italy

Investor stats

  • Total investments: 12
  • Round size: Venture - Series Unknown $910k–$4.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VENPA — Noleggio Piattaforme Aeree e Noleggio Macchine Movimento Terra. Scopri tutti i mezzi da cantiere Venpa!
  • Tony Kart — Tony Kart is an automotive company specializing in designing and manufacturing chassis, OTK kart parts, and karting wears.
  • Hippocrates — Hippocrates operates a pharmacy platform with a network of over 120 owned pharmacies concentrated in central and northern Italy. Since its foundation, it has approached the pharmacy sector with an industrial and long-term logic. The company was founded in March 2018 by Davide Tavaniello and Rodolfo Guarino, co-CEOs of Hippocrates.
Show all investments...

Principia SGR
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Venture - Series Unknown
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 50
  • Round size: Series A $1.5M–$7.9M; Venture - Series Unknown $7.2M–$9.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2014

Portfolio highlights

  • KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Show all investments...

Luca Trevisan
Angel · Siena, Toscana, Italy · 2 investments in Italy Medical startups

Luca Trevisan Sales Manager and Business Coordinator.

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Series A
  • Geography: Italy

Investor stats

  • Total investments: 2
  • Round size: Series A $750k–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 2 investments in Italy Medical startups

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Ireland, United States, France

Investor stats

  • Total investments: 57
  • Round size: Series A $6.3M–$35M; Series B $5.5M–$68M; Series C $3.3M–$110M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $140M in 2019

Portfolio highlights

  • Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Show all investments...

Equiter
VC Fund · Turin, Piemonte, Italy · 2 investments in Italy Medical startups

Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.

Show more...

Investment focus

  • Industry: Medical, Health Care, Information Technology
  • Stage:Seed, Series B
  • Geography: Italy

Investor stats

  • Total investments: 8
  • Round size: Seed $2.2M–$4M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
  • Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
  • Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Italy Medical startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Health Care
  • Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
  • Geography: France, Germany, Spain

Investor stats

  • Total investments: 595
  • Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Club degli Investitori
VC Fund · Torino, Piemonte, Italy · 2 investments in Italy Medical startups, 7 in the past 12 months

Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 118
  • Round size: Seed $197k–$8.4M; Pre-Seed $204k–$1.9M; Series A $889k–$30M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
  • Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

P101
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups, 7 in the past 12 months

P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, Spain, United States

Investor stats

  • Total investments: 121
  • Round size: Seed $270k–$4M; Series A $2.3M–$15M; Venture - Series Unknown $721k–$8.2M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: Likely still investing — raised $265M in 2022

Portfolio highlights

  • Biorsaf — Biorsaf is an IT company that develops mobile apps and web control panels to assist companies to bring efficiency to their operations.
  • Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
  • A-Cube — A-Cube API: la piattaforma globale per la Tax Compliance. Integra la fatturazione elettronica e gli obblighi fiscali in ogni ERP o e-commerce in Italia e nel mondo.
Show all investments...

ENEA Tech e Biomedical
VC Fund · Rome, Lazio, Italy · 2 investments in Italy Medical startups

ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Venture - Series Unknown, Series A, Grant
  • Geography: Italy, Finland

Investor stats

  • Total investments: 13
  • Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
  • Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
  • Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Show all investments...

Fin Posillipo Spa
VC Fund · 2 investments in Italy Medical startups

Familiy Office of Petrone Group

Show more...

Investment focus

  • Industry: Sales, Medical, Internet
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $140k–$162k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Verado — Verado is a global technology platform designed to empower everyone to instantly monetize their belongings. Whether selling an old laptop or unlocking cash by collateralizing valuables for a loan, our technology is crafted to enable consumers to do so with unprecedented ease. Snap a picture of your electronics, valuables, apparel or otherbelongings, get an instant appraisal through our real time valuation engine, and receive a direct payout to your bank account immediately. We are a deep technology company, envisioning a world where products’ lifecycle is lengthened and the ecological burden of trashing minimised. What exists currently is falling short of the experience modern consumers expect. They value convenience, comfort and speed, and don’t deem existing selling channels even marginally satisfactory. They are tired of the tedious paper-work, negotiating with uncommitted buyers through outdated messaging systems, managing the logistics, and the time-consuming nature of the process. Through our innovative solutions, we are cutting down from days to seconds the time it takes to receive a valuation; and from weeks to hours, the time necessary to sell!Verado is changing the rules of the game - It’s simplicity, re-engineered. We believe selling should be as seamless as buying. Therefore, rather than accumulating unused products at home or worse letting them end up in a landfill forever - we enable individuals to monetize their unwanted things, free up valuable space in their home and reduce their need for borrowing whilst simultaneously minimizing their ecological footprint.
  • BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.
Show all investments...

Sefea Impact
VC Fund · Padua, Veneto, Italy · 2 investments in Italy Medical startups

Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.

Show more...

Investment focus

  • Industry: Medical, Health Care, Information Services
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Italy

Investor stats

  • Total investments: 8
  • Round size: Venture - Series Unknown $777k–$5.9M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
  • BionIT Labs — BionIT Labs is an Italian-U.S. company developing prosthetic and robotic technologies built around how humans move, perceive, and interact with the physical world.
  • Planeat.eco — Planeat.eco is the site where you can plan your food shopping in a simple and economical way, starting from the recipes and receiving at home all the ingredients ready for preparation , weighed and divided into compostable containers. They offer their products online.
Show all investments...

Neva SGR
VC Fund · Turin, Piemonte, Italy · 2 investments in Italy Medical startups

Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.

Show more...

Investment focus

  • Industry: Software, FinTech, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Italy, United States, Israel

Investor stats

  • Total investments: 52
  • Round size: Series A $6M–$64M; Series B $17M–$141M; Series C $28M–$110M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • iwoca — Iwoca provides financing to businesses for various purposes, including bridging short-term cashflow gaps and investing in stock opportunities. It services retailers, restaurants, hotels, and other businesses. It offers flexible repayment options from 1 day to 24 months, with no penalties for early repayment. Iwoca helps businesses manage cash flowgaps and invest in growth opportunities, enhancing their financial capabilities.
  • Straiker — Security for agentic AI applications built from the ground up with fine-tuned models to protect and secure every layer of your agentic AI stack.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Show all investments...

Fondazione Social Venture Giordano dell'Amore
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

FSVGDA aims at the promotion of the impact investing culture, in order to facilitate social innovation.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Venture - Series Unknown, Seed, Pre-Seed
  • Geography: Italy, Mexico

Investor stats

  • Total investments: 31
  • Round size: Seed $205k–$603k; Venture - Series Unknown $29k–$841k
  • Lead/follow: 65% lead, 35% follow

Portfolio highlights

  • C.NEXT — C.NEXT develops innovation projects for businesses and organizations by supporting the economy and territorial regeneration.
  • Vivavoce — Il centro medico Vivavoce, Specializzato nel trattamento riabilitativo della #balbuzie. Disturbi del Linguaggio, DSA, Psicologia e Neuropsichiatria infantile.
  • Way Experience — Way Experience operates in all the entertainment B2C sectors, using augmented and virtual reality technology. They also work in the B2B area by applying their technologies for customized consultancy projects in the following sectors: design, fashion, medical, events, and training.
Show all investments...

Lumen Ventures
VC Fund · London, England, United Kingdom · 2 investments in Italy Medical startups

Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $1.4M–$5.3M; Series A $5.3M–$14M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $29M in 2020

Portfolio highlights

  • qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
  • Serenis Health — Serenis Health provides video-based psychotherapy, coaching, and psychological support courses. It believes that the internet is critical to increasing access to mental health care. It makes use of data and digital tools to improve the efficacy of therapies. But, unlike other platforms, it is also a medical center, which means it is responsible forcourse quality and must meet the same standards as any polyclinic.
  • AutoConnexa — Scopri AutoConnexa, l'assicurazione online per la tua auto che premia lo stile di guida. Con Drive Connexa, meglio guidi e meno paghi.
Show all investments...

3B Future Health Fund
VC Fund · Monaco, Bayern, Germany · 2 investments in Italy Medical startups

Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series B, Series A, Seed
  • Geography: United States, Italy, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Seed $1.5M–$11M; Series A $2.8M–$41M; Series B $7.4M–$75M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • GenEp — GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.
  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • Navion Neurosciences — Navion Neurosciences is a preclinical-stage biotechnology company developing next-generation, precision sodium channel therapies for neurological diseases.
Show all investments...

Opes Italia
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.

Show more...

Investment focus

  • Industry: E-Commerce, Leisure, Medical
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Italy, Spain

Investor stats

  • Total investments: 13
  • Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
  • Lead/follow: 77% lead, 23% follow

Portfolio highlights

  • Baluwo — Providing basic essentials has never been this easy. Sending money is not always the solution so we provide easy, fast & convenient ways to send prepaid electricity top-ups, mobile top-ups and basic food items to support your family back home in The Gambia, and very soon in Senegal and Nigeria.
  • Freedome — Freedome is the leading marketplace for outdoor activities in Italy
  • GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Antin Infrastructure Partners
VC Fund · Paris, Ile-de-France, France · 2 investments in Italy Medical startups

Antin Infrastructure Partners is a leading private equity firm focused on infrastructure investments.

Show more...

Investment focus

  • Industry: Energy, Renewable Energy, Commercial
  • Stage:Private Equity, Seed
  • Geography: United States, Italy, United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Private Equity $108M–$1B
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely still investing — raised $1.3B in 2023

Portfolio highlights

  • CityFibre — CityFibre is a brand new full fibre network built for the data age. Never worry about speed or reliability again. Connect your home and business today.
  • Power Dot — Powerdot offers electric vehicle charging solutions in convenient locations across six European countries.
  • Origis Energy — Origis Energy is powering the solar revolution with solar power and energy storage projects for utility, corporate and public sector energy clients.
Show all investments...

Alchimia Investments
VC Fund · Rome, Lazio, Italy · 2 investments in Italy Medical startups

Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Italy, United Kingdom, Israel

Investor stats

  • Total investments: 21
  • Round size: Seed $2.3M–$11M; Series A $4.4M–$40M; Venture - Series Unknown $5.8M–$14M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Stellar — At Stellar we bring perfect internet on the move to vehicles and passengers, leveraging the combined strength of cellular, wi-fi, and satellite networks, through AI and fully integrated solutions. We offer SaaS, data plans, and all-inclusive options for enterprise connectivity needs on the move.
Show all investments...

The Techshop
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

The Techshop is a venture capital and private equity firm that invests in B2B digital startups.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, Portugal, Switzerland

Investor stats

  • Total investments: 29
  • Round size: Seed $2M–$8.1M; Pre-Seed $322k–$37M; Series A $7.7M–$120M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • CiaoDott — Automatizza le telefonate, prenotazioni e FAQ del tuo studio medico con CiaoDott, l'assistente vocale AI disponibile 24/7. Provalo gratis.
  • Octostar — Octostar is the sovereign, AI-powered investigative intelligence platform for law enforcement, national security and financial institutions.
  • Helix Robotics — We are building the first commercial soft manipulator
Show all investments...

Evotec
VC Fund · Hamburg, Hamburg, Germany · 2 investments in Italy Medical startups

Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 29
  • Round size: Series A $8.5M–$95M; Series B $21M–$139M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Show all investments...

Green Arrow Capital
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Medical startups

Green Arrow Capital is an independent financial group specializing in alternative investments across Europe. They represent a one-of-a-kind platform, capable of connecting the financial system with the real economy through the management of private equity, private debt, infrastructure, and special credit situation funds as well as thematic fundssuch as microfinance and funds of funds that are currently under management. Their team has a successful track record in asset management, investment banking, industry sectors, technology startups, management consulting, renewable energy, and has government and regulatory experience. Their group is mainly composed of investment, asset management, and financial advisory companies. Their aim is to create a solid financial platform to launch and manage investment funds dedicated to alternatives and to the real economy.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 9
  • Round size: Series A $1.5M–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Directa Plus — Directa Plus is a nanotechnology company, manufactures nanoparticles.
  • Maticmind S.p.A — Maticmind S.p.A is a company that provides ICT and system integration solutions to telecommunications operators.
  • Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Show all investments...

Fondazione Golinelli
VC Fund · Bologna, Emilia-Romagna, Italy · 1 investments in Italy Medical startups

Fondazione Golinelli was born in Bologna in 1988 by the will of the entrepreneur and philanthropist Marino Golinelli with the aim to promote education and training, to promote the culture, to foster intellectual growth and ethics of young people, the citizens of tomorrow.

Show more...

Investment focus

  • Industry: FinTech, Medical, Biotechnology
  • Stage:Seed, Pre-Seed, Grant
  • Geography: Italy

Investor stats

  • Total investments: 7
  • Round size: Seed $146k–$534k
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Biorfarm — Adotta il tuo Albero, crea il tuo Campo Digitale e ricevi a domicilio la tua frutta biologica. Solo con Biorfarm puoi seguire la crescita dei tuoi frutti!
  • EvenFi — Criptalia uses blockchain technology to connect businesses that have projects to be funded with people and organizations who are looking for high-yield investments. We offer an online platform where companies publish their innovative ideas and industrial improvement projects. Investors, people, and institutions can fund these projects by lendingmoney in exchange for a higher interest rate.
  • Latitudo40 — Empower sustainable growth with AI-driven satellite insights from Latitudo 40. Unlock precise, real-time data for smarter urban planning, climate risk management, and industry innovation. Enhance resilience and lead with confidence.
Show all investments...

Padda Health
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Medical startups

Siamo partner di private equity con una struttura family office. Selezioniamo start-up tech-driven con idee innovative e voglia di emergere.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Medical
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Italy, Germany, Luxembourg

Investor stats

  • Total investments: 6
  • Round size: Seed $1.4M–$2.6M; Pre-Seed $244k–$285k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TeiaCare — TeiaCare is an Italian start-up born in 2018 with the aim of transferring technology and innovation knowledge to care homes.Our first solution, Ancelia, is an AI-powered operating system designed to increase transparency in the care and assistance processes, both inside the care home and towards residents' families.TeiaCare, based inMilan, operates in Italy and Spain, has a team of 15 people and is supported by international investors.
  • VoiceMed — We bring deep-tech innovation into your smartphone. With vocal biomarkers and artificial intelligence, we measure respiratory diseases.
  • Hale — Hale is the digital solution supporting people with genito-pelvic pain, helping them live better with their condition. Download our app now!
Show all investments...

Giovanni Cerutti
Angel · Milan, Lombardia, Italy · 1 investments in Italy Medical startups

Giovanni Cerutti is a chief executive officer & managing director at NOVAICOS.

Show more...

Investment focus

  • Industry: Medical, Wellness, Health Care
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Show all investments...

Kairos Partners
VC Fund · Milan, Michigan, United States · 1 investments in Italy Medical startups

Kairos Partners SGR is a independent Italian asset management company.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Fashion
  • Stage:Seed, Series A
  • Geography: Italy

Investor stats

  • Total investments: 5
  • Round size: Seed $2M–$11M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Viceversa — Viceversa provides capital to European digital businesses to support companies in sustainable and ethical growth. The company was founded in 2021 and has locations in Milan and Dublin.
  • Hercle — Hercle is a regulated digital asset liquidity provider specializing in OTC trading and market making.
  • Underscore District — Underscore District unlocks the potential of Made in Italy fashion brands through the power of technology and data analytics.
Show all investments...

Spindial Group
VC Fund · 1 investments in Italy Medical startups

Spindial Group

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Glomeria Therapeutics — Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis.Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Romed
VC Fund · 1 investments in Italy Medical startups

Romed is an investment firm.

Show more...

Investment focus

  • Industry: Medical, Wellness, Health Care
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Show all investments...

VI Partners
VC Fund · Altendorf, Schwyz, Switzerland · 1 investments in Italy Medical startups

Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: Switzerland, Germany, United States

Investor stats

  • Total investments: 110
  • Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $117M in 2020

Portfolio highlights

  • Altoida — Altoida is creating a new gold standard in brain health with Precision Neurology. We're radically transforming the method for measuring brain function and diagnosing neurological disease, using just your smartphone or tablet.Our products are backed by more than 20 years of innovative research in digital biomarkers, augmented reality (AR),and artificial intelligence (AI).Altoida received FDA Breakthrough Device Designation in July 2021. Our first device is a Computerized Cognitive Assessment Aid that is classified as Class II, 510(k) exempt.
  • SMART VALOR — SMART VALOR is a secure investment platform offering easy buy and sell of cryptocurrencies like Bitcoin, Ethereum, Dash and more. Trade and store digital assets.
  • JenaValve Technology — Redefining what it means to treat patients with severe aortic regurgitation.
Show all investments...

Seroba Life Sciences
VC Fund · Dublin, Dublin, Ireland · 1 investments in Italy Medical startups

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 48
  • Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $111M in 2017

Portfolio highlights

  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Novate Medical — NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device thatsimultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.
  • INNOVO by Atlantic Therapeutics — INNOVO is a completely non-invasive, clinically proven and long-lasting solution to urinary incontinence and bladder weakness. See results in 4 weeks!
Show all investments...

RoboIT
VC Fund · 1 investments in Italy Medical startups

RoboIT is the National Technology Transfer Hub for Robotics and Industrial Automation.

Show more...

Investment focus

  • Industry: Medical, Manufacturing, Medical Device
  • Stage:Pre-Seed
  • Geography: Italy

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • SunCubes — SunCubes is an innovative startup developing wireless energy transmission technologies using lasers, enabling applications like drone recharging and remote sensor power, driving efficiency.
  • Eye2Drive — EYE2DRIVE is a young company designing and building a new imaging sensor for the autonomous cars. We are based in Tuscany, Italy.
  • PhotonPath — Enabling seamless integration between Photonics and Electronics for a faster, more connected and sustainable future
Show all investments...

Growth Engine
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Medical startups

Growth Engine is a Venture Capital holding investing in Pre-Seed and Seed high-potential opportunities. With a current portfolio of more than 40 companies, most of them evolved in successful Scaleups, Growth Engine is a diversified asset class by sector and stage. Growth Engine Shareholders are entrepreneurs who have built companies from the groundup, collectively creating billions in value, and top executives managing companies with multi-billion-dollar valuations.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Secondary Market, Convertible Note
  • Geography: Italy, Mexico, United Kingdom

Investor stats

  • Total investments: 45
  • Lead/follow: no public data

Portfolio highlights

  • BonusX — Con l'app BonusX hai un supporto anti-burocrazia tutto l'anno. Accedi a centinaia di bonus e servizi pubblici, senza stress e code.
  • WithLess — Apps multiply, costs grow, admin spirals. We get it. The tools your team needs WithLess time, money, and admin.
  • Vivaio Ventures — Vivaio Ventures partners with early-stage and creator-led consumer brands to scale food, beverage, and beauty products. We offer capital, consulting, and Made in Italy manufacturing excellence for the next CPG leaders.
Show all investments...

RECOMEC
VC Fund · 1 investments in Italy Medical startups

RECOMEC operates as a venture capital firm that primarily invests in the healthcare sector.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Show all investments...

Fondazione Cottino
VC Fund · 1 investments in Italy Medical startups

Fondazione Cottino is support young people in their educational path and support for scientific research, technology transfer.

Show more...

Investment focus

  • Industry: Medical, mHealth, Diabetes
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
Show all investments...

Ferrante Gaetani,
Angel · 1 investments in Italy Medical startups

Ferrante Gaetani,

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Series A
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Show all investments...

Metaventures
VC Fund · Leeds, Leeds, United Kingdom · 1 investments in Italy Medical startups

We invest in the Metaverse

Show more...

Investment focus

  • Industry: Gaming, Medical, PC Games
  • Stage:Venture - Series Unknown
  • Geography: Italy, Brazil, United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $174k–$8M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • 4MDG — 4MDG creates a master data governance software suite that aims to provide management, sanitization, and enrichment of all kinds of information. Their platform focuses on registry cleaning, data governance, data analysis, integrated solutions, and differentiated products, providing businesses with real-time data, automated processes, data integrity,risk reduction, and improved operational efficiency in master data management.
  • Dubit — Choose your path in the Metaverse.
  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Show all investments...

Claris Ventures
VC Fund · Torino, Piemonte, Italy · 1 investments in Italy Medical startups

Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 11
  • Round size: Seed $2.2M–$11M; Series A $6.1M–$25M; Series B $7.9M–$20M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
  • ALKemist Bio — ALKemist Bio is a biotech startup developing next-generation T cell therapies that target ALK-positive cancers. By reprogramming the immune system, the company aims to overcome resistance and deliver more effective, lasting treatments for solid tumors.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Show all investments...

Medical Investor funding in Italy at a glance

Stats across 178 deals from 203 investors.

203
investors
in Italy Medical startups
178
deals
in Italy Medical startups
$1.9M
median round
in Italy Medical startups
36%
lead investors
lead at least one round
22%
Grant
most common funding stage
93/7
VC / Angel
share of investor count

Access all 203 investors in Italy Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 203 investors investing in Italy Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists